- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 11/00 - Drugs for disorders of the respiratory system
Patent holdings for IPC class A61P 11/00
Total number of patents in this class: 10438
10-year publication summary
|
334
|
378
|
323
|
599
|
618
|
721
|
1203
|
1004
|
1088
|
233
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Mondobiotech Laboratories AG | 311 |
289 |
| Boehringer Ingelheim International GmbH | 4629 |
180 |
| AstraZeneca AB | 3042 |
174 |
| Chiesi Farmaceutici S.p.A. | 940 |
164 |
| Novartis AG | 11238 |
124 |
| Vertex Pharmaceuticals Incorporated | 1581 |
116 |
| F. Hoffmann-La Roche AG | 7958 |
69 |
| Daiichi Sankyo Company, Limited | 1829 |
68 |
| Takeda Pharmaceutical Company Limited | 2961 |
65 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3314 |
62 |
| Glaxosmithkline Intellectual Property Development Limited | 723 |
58 |
| Theravance Biopharma R&D IP, LLC | 550 |
53 |
| Genentech, Inc. | 3742 |
50 |
| Bayer Pharma AG | 1096 |
48 |
| The Regents of the University of California | 18943 |
47 |
| Bayer AG | 3045 |
46 |
| Boehringer Ingelheim Pharma GmbH & Co. Kg | 790 |
45 |
| Bristol-myers Squibb Company | 5080 |
44 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 2912 |
43 |
| Galapagos NV | 304 |
39 |
| Other owners | 8654 |